Skip to content

Clinical trials

Completed Glioblastoma trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioblastoma Status: Completed Country / region: Australia Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20061
20081
20091
20112
20124
20131
20144
20154
20174
20181
20192
20202
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
AbbVie3
Eli Lilly and Company3
Hoffmann-La Roche2
Nativis, Inc.2
Amgen1
AstraZeneca1
BeiGene USA, Inc.1
Bristol-Myers Squibb1
Celldex Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma31
Brain Neoplasms8
Astrocytoma6
Gliosarcoma5
Neoplasms5
Glioma4
Central Nervous System Neoplasms3
Colorectal Neoplasms3
Stomach Neoplasms3
Breast Neoplasms2

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.